Strides Pharma Science Ltd

NSE: STAR · BSE: 532531 · Pharmaceuticals & Biotechnology · 7 announcements

Share price: ₹1,184.90
Market cap: ₹10,922 Cr
Revenue (annual): ₹4,859 Cr
Net profit (annual): ₹556.2 Cr
P/E (TTM): 17.8×Sector 50.4×
Promoter holding: 27.91%+0.00% QoQ
FII holding: 28.40%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 2 Financial Results 1 Business Update 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

3 Aug 2026 17:24 IST BSE

Earnings Call

Strides Pharma Science Earnings Call Transcript: Key Takeaways

Strides Pharma Science reported Q1 FY27 results with 13% YoY revenue growth and EBITDA margins maintained at 18.2%. Strategy focuses on Ex-US growth and US portfolio diversification.

Call: Guides 32% growth

Open call summary → Read the filing ↗

31 Jul 2026 12:42 IST NSE

Earnings Call

Strides Pharma Science Investor Presentation: Key Takeaways

Strides Q1FY27 revenue grew 13% YoY to ₹12,654m, led by a 17% surge in Ex-US markets. Operational PAT stood at ₹1,231m.

Open call summary → Read the filing ↗